Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study.
Inflamm Bowel Dis. 2019 Sep 27;:
Authors: Clarke WT, Papamichael K, Casteele NV, Germansky KA, Feuerstein JD, Melmed GY, Siegel CA, Irving PM, Cheifetz AS
PMID: 31559417 [PubMed – as supplied by publisher]